Home/ Stocks/ NSPR

InspireMD, Inc.

NSPR XNAS

$0.74 +0.02 (+2.58%) ▲ 15-min delayed

Open

$0.70

High

$0.75

Low

$0.68

Volume

50.1K

Market Cap

$33.83M

About InspireMD, Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 127 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$3.40M	$-13,689,000	$-0.16
FY 2025	$8.98M	$-48,786,000	$-0.76
Q3 2025	$2.52M	$-12,708,000	$-0.17
Q2 2025	$1.78M	$-13,151,000	$-0.26

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for NSPR yet. Check out our latest market news or earnings calendar.

Get NSPR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on InspireMD, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.